Condition
Migraine Disorders clinical trials and research
As of November 12, 2026, Find a Trial lists 16 Migraine Disorders clinical trials that are recruiting, at sites in 9 countries (most in United States (5), China (2), France (2)). By phase: Phase 4 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 16Clinical trials
- 9Countries
Newest Migraine Disorders clinical trials
All recruiting trials (16)
-
HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry
This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.
-
MMA Embolization for Migraine: Patient-Reported Outcomes from a Single Site
This registry tests whether adults with migraine who have or plan to have middle meningeal artery embolization notice changes in headaches and quality of life over time.
-
Greater Occipital Nerve Block for Migraine with Medication Overuse Headache
This study will test whether a nerve block using lidocaine and methylprednisolone can help people with migraine who overuse medications to reduce withdrawal headaches during detoxification.
-
Closing a PFO to improve glymphatic function and migraine symptoms
This study will see if closing a patent foramen ovale (PFO) improves glymphatic system function and reduces migraine attacks in adults with PFO and migraine.
-
Italian Migraine Registry (I-GRAINE-NEW)
This registry will collect past and future clinical and healthcare data from adults with episodic or chronic migraine who come to specialized headache centers in Italy to better understand how the condition evolves and is treated.
-
Topical cannabidiol (Canvert-M) for migraine attacks
This will test whether applying Canvert-M, a topical roll-on with cannabidiol and essential oils, can reduce pain during migraine attacks in adults aged 18–55.
-
Using closed-loop rTMS to prevent migraines
This study is testing if a new type of brain stimulation can help people who get frequent migraines feel better and have fewer headaches.
-
Auricular neuromodulation for episodic migraine
This study will try a small electrical stimulation of the ear (auricular neuromodulation) to see if it reduces migraine days in adults 18–60 with moderate-to-severe episodic migraine who have not responded to at least two preventive medications.
-
Immune signals and regulatory T cells in migraine
This research will test whether blood immune markers and regulatory T cells are linked to migraine in women ages 18–50 who have migraine or certain autoimmune/inflammatory conditions.
-
Comparing telehealth cognitive behavioral therapy for youth with migraines
This study is testing whether online therapy for kids and teens with migraines works better when combined with medication or on its own.
-
Transcranial Direct Current Stimulation for Long COVID with Headaches and Chronic Pain
This study tests whether applying mild brain stimulation (tDCS) can help people with long COVID who have headaches, migraines, and ongoing pain.
-
Assessing the effectiveness of eptinezumab for migraine treatment in real-world settings
This study is testing how well eptinezumab, an IV treatment for migraines, works in real life for people who have frequent migraines and haven't had success with other treatments.
-
Evaluating a lifestyle intervention for chronic migraine management
This study is testing a new lifestyle program to see if it can help people with chronic migraines feel better compared to a control group.
-
Survey on long-term use of AJOVY for migraine treatment
This study is looking to see how safe AJOVY is for people using it to treat migraines over a long time, especially regarding heart-related issues.
-
Using Qudexy XR to prevent migraines in children aged 6 to 11
This study is testing if Qudexy XR can help prevent migraines in children aged 6 to 11 who have a history of headaches.
-
Using Idebenone to prevent migraines
This study is testing if a new compound called idebenone can help prevent migraines in adults by seeing if it reduces the number of migraine attacks compared to a placebo.
Related topics
Quick answers
How many Migraine Disorders clinical trials are recruiting right now?
16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in United States (5 trials), China (2 trials), France (2 trials), Italy (2 trials), Iran (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.